Acasti Pharma Stock Price, News & Analysis (CVE:ACST)

C$1.91 -0.02 (-1.04 %)
(As of 12/15/2017 02:58 AM ET)
Previous CloseC$1.93
Today's RangeC$1.90 - C$2.02
52-Week RangeC$1.47 - C$2.99
Volume8,852 shs
Average Volume7,606 shs
Market CapitalizationC$30.33 million
P/E RatioN/A
Dividend YieldN/A
Beta1.47

About Acasti Pharma (CVE:ACST)

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. The company's lead product candidate is CaPre, an omega-3 phospholipid for the treatment of hypertriglyceridemia. Acasti Pharma Inc. was incorporated in 2002 and is based in Laval, Canada.

Receive ACST News and Ratings via Email

Sign-up to receive the latest news and ratings for ACST and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolCVE:ACST
CUSIPN/A
Phone+1-450-6872262

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSC($1.00)
Net IncomeN/A
Net MarginsN/A
Return on Equity-54.78%
Return on Assets-46.44%

Miscellaneous

EmployeesN/A
Outstanding Shares14,797,000

Acasti Pharma (CVE:ACST) Frequently Asked Questions

What is Acasti Pharma's stock symbol?

Acasti Pharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ACST."

Who are some of Acasti Pharma's key competitors?

Who are Acasti Pharma's key executives?

Acasti Pharma's management team includes the folowing people:

  • Roderick Noel Carter, Executive Chairman of the Board
  • Janelle D'Alvise, President, Chief Executive Officer, Director
  • Linda Parinella O'Keefe, Chief Financial Officer
  • Pierre Lemieux Ph.D., Chief Operating Officer
  • Laurent Harvey, Vice President- Clinical and Non-Clinical Affairs
  • Jean-Daniel Belanger, Secretary, Director- Corporate Affairs
  • Jean-Marie Canan, Director (Age 60)
  • Katherine Crewe, Director
  • Richard P. Schottenfeld, Director

How do I buy Acasti Pharma stock?

Shares of Acasti Pharma and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Acasti Pharma's stock price today?

One share of Acasti Pharma stock can currently be purchased for approximately C$1.91.

How big of a company is Acasti Pharma?

Acasti Pharma has a market capitalization of C$30.33 million.

How can I contact Acasti Pharma?

Acasti Pharma's mailing address is 545 Prom du Centropolis Suite 100, LAVAL, QC H7T 0A3, Canada. The company can be reached via phone at +1-450-6872262.


MarketBeat Community Rating for Acasti Pharma (ACST)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  15 (Vote Outperform)
Underperform Votes:  19 (Vote Underperform)
Total Votes:  34
MarketBeat's community ratings are surveys of what our community members think about Acasti Pharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Acasti Pharma (CVE:ACST) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for Acasti Pharma (CVE:ACST)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Acasti Pharma (CVE:ACST) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Acasti Pharma (CVE:ACST)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Acasti Pharma (CVE ACST) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Acasti Pharma (CVE:ACST)

Acasti Pharma (CVE ACST) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/21/2017Jean-Daniel BélangerDirectorSell51,199C$2.41C$123,389.59
(Data available from 1/1/2013 forward)

Headlines

Acasti Pharma (CVE ACST) News Headlines

Source:
DateHeadline
Acasti Pharma Inc. (ACST) Director Jean-Daniel Bélanger Sells 51,199 SharesAcasti Pharma Inc. (ACST) Director Jean-Daniel Bélanger Sells 51,199 Shares
www.americanbankingnews.com - November 23 at 1:24 PM
IIROC Trading Resumption - ACSTIIROC Trading Resumption - ACST
www.bizjournals.com - November 23 at 12:41 AM
Acasti Pharma (ACST) Clarifies Term of Proposed Strategic Partnership in ChinaAcasti Pharma (ACST) Clarifies Term of Proposed Strategic Partnership in China
www.streetinsider.com - November 23 at 12:41 AM
Acasti Pharma advancing potential deal to commercialize CaPre in Asia; shares ahead 75% - Seeking AlphaAcasti Pharma advancing potential deal to commercialize CaPre in Asia; shares ahead 75% - Seeking Alpha
seekingalpha.com - November 20 at 10:02 PM

SEC Filings

Acasti Pharma (CVE:ACST) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Acasti Pharma (CVE ACST) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.